Boaz Weinstein Saba Capital Management
Boaz Weinstein is the founder of Saba Capital Management, a firm known for credit, derivatives, and event-driven strategies. He previously built a major credit trading franchise at Deutsche Bank before launching Saba. Weinstein is also widely followed for activism in closed-end funds and for views on credit markets and volatility.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GLO
Clough Global Opportunities Fund
GLO
|
+$34.6M |
| 2 |
GAM
General American Investors Company
GAM
|
+$30.3M |
| 3 |
Bausch Health
BHC
|
+$18.1M |
| 4 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
+$15.4M |
| 5 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$9.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$31.5M |
| 2 |
FTF
Franklin Limited Duration Income Trust
FTF
|
+$28M |
| 3 |
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
|
+$23.4M |
| 4 |
PPT
Franklin Premier Income Trust
PPT
|
+$9.99M |
| 5 |
BlackRock Multi-Sector Income Trust
BIT
|
+$6.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Financials | 2.02% |
| 3 | Industrials | 1.55% |
| 4 | Energy | 1.05% |
| 5 | Consumer Discretionary | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BGX
101
Blackstone Long-Short Credit Income Fund
BGX
$137M
| – | – |
-137,738
| Closed | -$2.19M |
|
|
DSL
102
DoubleLine Income Solutions Fund
DSL
$1.21B
| – | – |
-74,514
| Closed | -$1.42M |
|
|
EVG
103
Eaton Vance Short Duration Diversified Income Fund
EVG
$142M
| – | – |
-17,610
| Closed | -$244K |
|
|
PPT
104
Franklin Premier Income Trust
PPT
$329M
| – | – |
-2,009,524
| Closed | -$9.99M |
|
105
Tesla
TSLA
$1.43T
| – | – |
-328,500
| Closed | -$5.56M |
|
|
VGI
106
Virtus Global Multi-Sector Income Fund
VGI
$82.5M
| – | – |
-33,247
| Closed | -$510K |
|
|
GAP
107
PUT
The Gap Inc
GAP
$7.13B
| – | – |
-450,600
| Closed | -$10.1M |
|
|
AIF
108
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| – | – |
-140,289
| Closed | -$2.17M |
|
|
IVH
109
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
| – | – |
-22,142
| Closed | -$327K |
|
|
AGN
110
CALL
DELISTED
Allergan plc
AGN
| – | – |
-134,900
| Closed | -$28.3M |
|
Similar funds
Boaz Weinstein's Q1 2017 Portfolio in Review
As of Q1 2017, Boaz Weinstein held 114 positions worth $1.12B, up 14% from $984M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Boaz Weinstein deployed $88.7M of net new capital in Q1 2017, opening 18 new positions and adding to 28 existing holdings. Its largest new stake was J.C. Penney Company, Inc.: 1,409,000 shares worth $8.68M.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Allergan plc, an estimated $31.5M trimmed.
- Boaz Weinstein's largest Q1 2017 buy was J.C. Penney Company, Inc.: 1,409,000 shares worth $8.68M.
- Boaz Weinstein added most to Clough Global Opportunities Fund in Q1 2017, an estimated $34.6M increase.
- Boaz Weinstein's biggest Q1 2017 reduction was Allergan plc, cutting an estimated $31.5M.
- Boaz Weinstein fully exited Blackstone Strategic Credit 2027 Term Fund in Q1 2017, selling an estimated $23.4M.
- Boaz Weinstein's ten largest holdings make up 51% of its $1.12B portfolio in Q1 2017.
- Boaz Weinstein opened 18 new positions and closed 11 in Q1 2017.
- Boaz Weinstein's portfolio value rose 14% quarter-over-quarter to $1.12B.
Based on Saba Capital Management's 13F filing for Q1 2017, filed 15 May 2017.